Posts

Watching paint dry — to understand and control the patt...

A coffee spill leaves behind a dark stain around the puddle’s edge when it dries...

Scientists figured out what causes Earth’s strongest li...

American Geophysical Union 28 September 2023 AGU Release No. 23-37 For Immediate...

Roundtable on ensuring ethical and equitable artificial...

The National Alliance against Disparities in Patient Health (NADPH) presents a R...

How parents’ work stress affects family mealtimes and c...

URBANA, Ill. – Family mealtimes are important for parents and children as a spac...

Indigenous community-first approach to more ethical mic...

UNIVERSITY PARK, Pa. — Every person hosts trillions of microorganisms, like bact...

‘Side-by-side’ utility terrain vehicles linked to high ...

September 28, 2023 – Recently popularized utility terrain vehicles (UTVs) with “...

Exciting news: 11 more journals indexed in CABI

Maximum Academic Press (MAP) is pleased to announce that 11 more journals includ...

Virginia Tech researchers awarded grant to increase und...

With the significant increase in industrial production of hemp, there is a deman...

Why are killer whales harassing and killing porpoises w...

For decades, fish-eating killer whales in the Pacific Northwest have been observ...

Making elbow room: Giant molecular rotors operate in so...

Solid materials are generally known to be rigid and unmoving, but scientists are...

Overcoming Age-Related Challenges in Nanodrug Delivery ...

The efficacy of medical treatments often varies with age, and this principle hol...

60 Degrees Pharmaceuticals Halts Tafenoquine COVID-19 T...

In accordance with FDA guidance, 60 Degrees Pharmaceuticals has opted to halt th...

Phase 3 trial data for Astellas’s GA drug yielded posit...

A mere six weeks after obtaining FDA approval, Astellas Pharma is already consid...

Morphic’s EMERALD-1 trial for ulcerative colitis disapp...

Investors have raised a concern about Morphic’s eagerly awaited EMERALD-1 trial....

Ionis sees success in lipid reduction Phase 3 trial

Ionis Pharmaceuticals has achieved a significant milestone in their phase 3 clin...

Arcturus Therapeutics extends cystic fibrosis treatment...

Arcturus Therapeutics has extended an existing agreement in place with the Cysti...